Dinuclear Dicationic Iridium Complexes for Highly Synergistic Photodynamic and Photothermal Therapy to Chemoresistant Cancer
Inorganic Chemistry · 2025
DOI: 10.1021/acs.inorgchem.4c04282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, 2025. Verfasst von Li-Zhen Zeng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Provincial Center for Research and Development of Natural P…. Hauptthemen laut MEDLINE: Iridium, Antineoplastic Agents, Photochemotherapy, Coordination Complexes. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Yunnan Provincial Science and Technology Department, Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
A series of dinuclear Ir(III) complexes have been constructed for enhanced photodynamic and photothermal therapy (PDT and PTT) for cisplatin-resistant non-small-cell lung cancer. They enter cells via caveolar endocytosis, target mitochondria but not nuclear, generate both singlet oxygen and superoxide anion, and release heat when exposed to infrared (IR) irradiation, thus inducing reactive oxygen species (ROS)-associated cell disruption and thermal ablation. The IR-generated ROS can further activate caspases, triggering apoptosis. Additionally, the ROS deplete intracellular glutathione, lead to lipid peroxidation, and induce ferroptosis. The selected dinuclear Ir(III) complex Ir4 can completely eradicate cisplatin-resistant non-small-cell lung tumor in 75% of the phototreated mice with an inhibition rate of tumor growth above 96%. They have an extremely low toxicity to normal liver and kidney cells. After therapy, metal was not detected in the collected organs of mice except the tumor. A synergistic therapy consisting of potent IR-driven PDT and mild PTT accomplished by single-molecule dinuclear Ir(III) complexes is highly significant for the safe and effective PDT of large, deep-seated tumors as well as for overcoming the complicated drug resistance mechanisms of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Provincial Center for Research and Development of Natural Products; School of Pharmacy, Yunnan University, Kunming 650500, P. R.…
- Animal Research and Resource Center, School of Life Sciences, Yunnan University, Kunming 650500, P. R. China.
ORCID-Profile: Feng Gao
Förderung
- Yunnan Provincial Science and Technology Department
- Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province
- National Natural Science Foundation of China
Zitieren
APA
Zeng, L. Z., Li, X. L., Deng, Y. A., Zhao, R. Y., Song, R., Yan, Y. F., Wang, M. F., Wang, X. H., Ren, X., & Gao, F. (2025). Dinuclear Dicationic Iridium Complexes for Highly Synergistic Photodynamic and Photothermal Therapy to Chemoresistant Cancer. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.4c04282
Vancouver
Zeng LZ, Li XL, Deng YA, Zhao RY, Song R, Yan YF, et al. Dinuclear Dicationic Iridium Complexes for Highly Synergistic Photodynamic and Photothermal Therapy to Chemoresistant Cancer. Inorganic Chemistry. 2025. doi:10.1021/acs.inorgchem.4c04282
BibTeX
@article{Zeng2025,
author = {Zeng, Li-Zhen and Li, Xue-Lian and Deng, Yu-Ang and Zhao, Run-Yu and Song, Ran and Yan, Yu-Fei and Wang, Meng-Fan and Wang, Xiang-Han and Ren, Xiaoxia and Gao, Feng},
title = {Dinuclear Dicationic Iridium Complexes for Highly Synergistic Photodynamic and Photothermal Therapy to Chemoresistant Cancer},
journal = {Inorganic Chemistry},
year = {2025},
doi = {10.1021/acs.inorgchem.4c04282}
}
EUVIMED